Skip to main content

Table 3 Baseline demographic data

From: Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)

 Venofer 200Cosmofer 200Monofer 200Monofer 1000Total group
Age, years (SEM)52.1 (4.3)64.2 (2.6)59.5 (5.0)59.3 (5.3)58.8 (2.2)
Male/female, numbers6/46/44/67/323/17
Serum ferritin, μg/L (SEM)58.5 (11.6)82.9 (21.8)64.7 (10.9)69.1 (18.4)68.8 (8.0)
Transferrin saturation percentage (SEM)21.1 (2.9)25.4 (4.9)21.2 (3.1)17.8 (1.7)21.4 (1.7)
Haemoglobin, g/L (SEM)122.1 (4.6)129.6 (7.5)123.0 (5.5)115.5 (4.5)122.6 (2.8)
Serum creatinine, micromole/L (SEM)279.2 (42.7)247.6 (39.3)176.2 (16.8)235.5 (22.5)234.6 (16.6)
eGFR, mL/min per 1.73 m2 (SEM)25.8 (5.1)26.3 (4.3)34.8 (4.2)26.2 (3.9)28.2 (2.2)
uACR, mg/mmol (SEM)74.1 (33.1)26.4 (8.8)167.0 (110.8)144.6 (50.5)107.9 (33.9)
uPCR, mg/mmol (SEM)105.9 (47.3)37.7 (12.6)238.6 (158.3)206.5 (72.2)154.2 (48.4)
Serum Albumin g/L (SEM)36.5 (1.02)38.0 (1.48)36.3 (1.56)35.1 (1.27)36.5 (0.67)
C-reactive protein, mg/L (SEM)8.1 (3.3)5.2 (1.8)9.7 (4.8)6.8 (2.6)7.5 (1.6)